Clinical Trials Directory

Trials / Completed

CompletedNCT01253486

Expressive Writing for Heart Healing

Use of Expressive Writing in the Cardiac Rehabilitation of Obese In-patients With Ischemic Heart Disease (IHD)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Istituto Auxologico Italiano · Academic / Other
Sex
All
Age
70 Years
Healthy volunteers
Not accepted

Summary

This study will determine whether the psychological and physical benefits of expressive writing extend to obese in-patients with Ischemic Heart Disease (IHD)referred to cardiac rehabilitation

Detailed description

Expressive writing, for as little as 3-5 sessions of 20 minutes, has been found to improve both physical and psychological health based on health outcome measures such as number of doctor's visits and hospital days, blood pressure control, lung and immune function, pain, anxiety and depression. Given its simplicity and obvious advantages in terms of cost-effectiveness, expressive writing has great potential as a therapeutic tool or as a means of self-help, either alone or as an adjunct to traditional therapies. This modality has not been studied in obese patients with Ischemic Heart Disease.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDisease-related Expressive writingParticipants in the disease-related expressive writing condition write about their feelings about cardiac disease four times, for at least 20 minutes each time, during a two week period.
BEHAVIORALActive Comparator: Traditional expressive writingParticipants in the traditional expressive writing condition write about their feelings about one or more stressful experiences they lived in the past, for at least 20 minutes each time, during a two week period
BEHAVIORALSham Comparator: Neutral writingParticipants in the neutral writing condition write about the facts about cardiac disease, for at least 20 minutes each time, during a two week period

Timeline

Start date
2010-01-01
Primary completion
2012-09-01
Completion
2013-05-01
First posted
2010-12-03
Last updated
2021-02-12

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01253486. Inclusion in this directory is not an endorsement.